Switch to:
More From Other Websites
Lannett To Participate At Two Investment Conferences In December Dec 07 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company,... Dec 06 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Dec 06 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett... Dec 05 2016
LCI NOTICE: Rosen Law Firm Reminds Lannett Company, Inc. Investors of Important Deadline in Class... Dec 05 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company,... Dec 02 2016
LANNETT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC... Dec 02 2016
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett Company,... Dec 02 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Dec 02 2016
ETFs with exposure to Lannett Co., Inc. : December 2, 2016 Dec 02 2016
Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : December 2, 2016 Dec 02 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company,... Dec 01 2016
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Lannett Company, Inc. Dec 01 2016
Lannett Provides Update On Methylphenidate ER Tablets Dec 01 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett... Nov 30 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lannett Company, Inc. of a Class... Nov 30 2016
FDA gives Lannett more time to fight for generic ADHD drug Nov 30 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Nov 30 2016
6:57 am Lannett announces that the FDA granted the company a 90-day extension to submit... Nov 30 2016
Lannett Provides Update On Methylphenidate ER Tablets Nov 30 2016
Lannett Announces Approval For Metaxalone Tablets USP, 800 Mg Nov 28 2016
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From... Nov 25 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company,... Nov 25 2016
Lannett Announces Approval For Memantine Hydrochloride Tablets USP, 5 mg And 10 mg Nov 14 2016
Lannett reports 1Q loss Nov 03 2016
Lannett Reports Fiscal 2017 First-Quarter Financial Results Nov 03 2016
Lannett Announces Successful Phase III Clinical Trial Results For Proprietary C-Topical® Product Oct 27 2016
Lannett To Report Fiscal 2017 First-Quarter Financial Results, Host Conference Call On Thursday,... Oct 27 2016
Lannett Comments On FDA Proposal Regarding Methylphenidate Extended Release Tablets Oct 19 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2... Sep 20 2016
Lannett Announces Successful FDA Inspections of Three Facilities Sep 19 2016
Lannett tops Street 4Q forecasts Aug 23 2016
Lannett Announces Record Net Sales For Fiscal 2016 Fourth-Quarter And Full-Year Aug 23 2016
Lannett To Report Fiscal 2016 Fourth-Quarter And Full-Year Financial Results, Host Conference Call... Aug 17 2016
Lannett Announces Senior Management Promotions Jul 25 2016
Lannett Announces Approval And Launch Of Paroxetine Extended Release Tablets USP, 12.5 Mg, 25 Mg,... Jul 11 2016
Lannett Receives FDA Approval For Diazepam Oral Solution, 5 mg/5 mL Jun 28 2016
Lannett Completes Repurchase Of Remaining $200 Million Of 12% Senior Notes Jun 20 2016
Lannett To Amend Credit Agreement To Repurchase Remaining $200 Million Of 12% Senior Notes Jun 14 2016
Lannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg Jun 13 2016
Lannett Completes $50 Million-Pay Down Of 12% Senior Notes May 27 2016
Lannett To Voluntarily Pay Down $50 Million Of 12% Senior Notes May 26 2016
Lannett To Present At Bank Of America Merrill Lynch 2016 Health Care Conference On May 11 May 05 2016
Lannett Reports Solid Fiscal 2016 Third Quarter Results May 03 2016
Lannett meets 2Q profit forecasts Feb 03 2016
Lannett to buy UCB unit to boost speciality generic drugs portfolio Sep 02 2015
Lannett beats Street 4Q forecasts Aug 25 2015
Lannett beats 3Q profit forecasts May 06 2015
Lannett beats 2Q profit forecasts Feb 04 2015
Lannett beats 1Q profit forecasts Nov 03 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK